quinazolines has been researched along with sepantronium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatashita, E; Kita, A; Kuwata, K; Nakagawa, K; Okamoto, I; Okamoto, K; Ono, M; Yamaguchi, H; Yamanaka, K | 1 |
| Elemento, O; Kapoor, TM; Kasap, C | 1 |
| Chang, CC; Chang, J; Chang, YC; Chang, YF; Cheng, CC; Ho, AS; Huang, L; Huang, SC; Lim, KH; Lin, HC; Wu, CW | 1 |
3 other study(ies) available for quinazolines and sepantronium
| Article | Year |
|---|---|
Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Naphthoquinones; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; RNA Interference; RNA, Small Interfering; Signal Transduction; Survivin | 2012 |
DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Resistance, Neoplasm; Endonucleases; Epigenesis, Genetic; Genome; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Kinesins; Molecular Targeted Therapy; Mutation; Naphthoquinones; Quinazolines | 2014 |
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
Topics: Afatinib; Antineoplastic Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; ErbB Receptors; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Imidazoles; Lung Neoplasms; Methylation; Naphthoquinones; Octamer Transcription Factor-3; Phosphorylation; Quinazolines; RNA, Messenger | 2017 |